White label ELPA - ClinicalTrials.eu

Study of Sacituzumab Govitecan, Pembrolizumab, and a Platinum Drug Combination for Advanced Non-Small Cell Lung Cancer Patients Without Genomic Alterations

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Gastrooesophageal cancer
Investigated drugs:
- Nivolumab
- Regorafenib
Study on the Effectiveness of Autologous Tumor-Infiltrating Lymphocytes, Aldesleukin, Fludarabine Phosphate, and Cyclophosphamide in Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+6
Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

Not recruiting

3 1 1
Investigated diseases:
- Open angle glaucoma
Investigated drugs:
- Bimatoprost
+1
Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington’s Disease

Not recruiting

2 1
Investigated diseases:
- Huntington’s disease
Investigated drugs:
- VOTOPLAM
Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Not recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Incb099280
Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

Not recruiting

2 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Elranatamab
Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

Not recruiting

3 1
Investigated diseases:
- Overweight
- Obesity
Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies